Panel Discussion: Biologics and biosimilars: The next leap in patient-centric drug development Read more
Remdesivir and favipiravir price regulation required to safeguard patients’ interest in India: GlobalData Read more
Gilead signs Voluntary Licensing Agreements with Cipla, Hetero Labs, Jubilant Lifesciences, Mylan for remdesivir Read more